Angiomiolipoma del rene: Un comune tumore renale benigno

Ultimo aggiornamento: 18 maggio 2026

• Facebook
• Instagram
• WordPress
• Telegramma
• WhatsApp
• LinkedIn
• Posta

Nel mio studio di urologia è stato riscontrato un tumore renale molto comune, il cosiddetto Angiomiolipoma (AML). Questo tumore viene riscontrato soprattutto nell'ambulatorio di promozione della salute e questo rende i pazienti molto preoccupati quando si incontrano per la prima volta con me. Questo è il motivo per cui discuteremo oggi.

Prima di tutto, devo confermare che l'angiomiolipoma è un tumore renale benigno. Sono stati riportati dati relativi a 0,2% - 0,6% nella popolazione generale e più comunemente si trovano nelle donne di mezza età. Le loro eziologie si dividono in 2 categorie

1. Sporadic or happens by itself without any causes – 80% of cases.
2. Genetic-related diseases, tuberosclerosis (TSC) or pulmonary lymphangioleiomyomatosis (LAM) – 20% of cases.

Since the most of Angiomyolipoma is asymptomatic, around 85% of cases are always incidentally finding from medical check up imaging. On the other hand, 15% of cases will symptomatically present.

Sintomi di sintomatico Angiomiolipoma

• Emorragia tumorale spontanea
• Massa palpabile sul fianco
• Dolore al fianco
• Minzione sanguinolenta
• Infezione delle vie urinarie

Diagnosis – Angiomyolipoma can be diagnosed by pure imaging modality since they have a unique composition which is “Fat” so once the imaging can detect renal tumor with fat component, AMLs will be a diagnosis.

1. Ultrasound – most common used modality. Pros: cheap, no radiation, widely accessible. Cons: operator dependent, less accurate for small AMLs.
2. Non-contrasted CT scan – Gold standard. Pros: definitive diagnosis. Cons: radiation exposure, expensive.
3. MRI – Alternative modality. Pros: accurate diagnosis. Cons: long scan time, expensive, contraindicated in metallic implanted patients.
4. Percutaneous biopsy – rarely used. Pros: tissue diagnosis. Cons: risk of hemorrhage.

Management options – There were confirmed literatures stating that less than 4 cm of AMLs can be reassured with no needing to do interventions. In contrast, if more than 4 cm AMLs have been reported, the possibility rupture event will increase. Treatment choices include active surveillance, embolization, surgery, and thermal ablation.

Il messaggio chiave che l'urologo deve trasmettere ai pazienti è che l'AML è un tumore benigno che nella maggior parte dei casi necessita solo di un programma di sorveglianza attiva. L'intervento è necessario in rari casi. Ci vediamo nel prossimo topic!

È possibile sentire il testo me qui.

Domande frequenti

Q1: Is angiomyolipoma of the kidney cancerous?

No. Angiomyolipoma (AML) is a benign (non-cancerous) kidney tumor. It is composed of fat, smooth muscle, and blood vessels, and is not malignant. However, larger AMLs carry a risk of spontaneous rupture and hemorrhage, which is why regular monitoring and sometimes intervention is recommended for tumors exceeding 4 cm in size.

Q2: What causes angiomyolipoma of the kidney?

In 80% of cases, angiomyolipoma occurs sporadically with no identifiable underlying cause. The remaining 20% are associated with genetic conditions, primarily tuberous sclerosis complex (TSC) or pulmonary lymphangioleiomyomatosis (LAM). AMLs are most commonly found in middle-aged women, though they can occur in both sexes.

Q3: When does angiomyolipoma need treatment?

AMLs smaller than 4 cm can generally be safely managed with active surveillance and regular imaging follow-up. Treatment becomes necessary when the tumor exceeds 4 cm, as larger AMLs carry a significantly higher risk of spontaneous rupture and life-threatening hemorrhage. Embolization is the preferred first-line minimally invasive treatment, with surgery reserved for cases suspicious of malignancy.

Q4: How is angiomyolipoma diagnosed?

AML can be diagnosed by imaging alone due to its characteristic fat content. Non-contrasted CT scan is the gold standard, as it can reliably detect fat within the tumor. Ultrasound is widely used at health check-up clinics as an initial screening tool, while MRI is an alternative for patients who cannot undergo CT. Percutaneous biopsy is rarely needed and reserved for atypical cases.

Q5: What symptoms does angiomyolipoma cause?

Approximately 85% of AMLs are asymptomatic and discovered incidentally during routine health check-up imaging. The remaining 15% may present with symptoms including flank pain, a palpable flank mass, bloody urination, urinary tract infection, or spontaneous tumor hemorrhage. Any new or worsening flank pain in a known AML patient should prompt urgent medical evaluation to rule out rupture.

If you have been told you have a kidney tumor or angiomyolipoma and would like a specialist assessment, Dr. Soarawee Weerasopone offers consultations at Bangkok Hospital Headquarters. Prenota una consulenza.

Disclaimer: Questo contenuto è redatto e revisionato dal Dr. Soarawee Weerasopone, urologo certificato presso il Bangkok Hospital Headquarters. È inteso solo a scopo educativo e non costituisce consulenza medica. Consultare sempre un professionista sanitario qualificato prima di iniziare qualsiasi trattamento medico.